Nanjing Medlander Medical Technology Co. Ltd. A (688273) — Capital Reinvestment Ratio
Nanjing Medlander Medical Technology Co. Ltd. A (688273) has a Capital Reinvestment Ratio of 1.06x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥122.51 Million) in capital expenditures (CN¥129.71 Million). See how leveraged is Nanjing Medlander Medical Technology Co.'s balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Nanjing Medlander Medical Technology Co. Ltd. A Capital Reinvestment Ratio (2020–2024)
This chart tracks Nanjing Medlander Medical Technology Co. Ltd. A's Capital Reinvestment Ratio across 5 annual periods. Check cash flow reinvestment rate of Nanjing Medlander Medical Technology Co. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)
Year-by-year Capital Reinvestment Ratio for Nanjing Medlander Medical Technology Co. Ltd. A from 2020 to 2024. For live market cap and broader valuation context, see market cap of Nanjing Medlander Medical Technology Co..
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.06x | CN¥122.51 Million | CN¥129.71 Million | ▲ +92.9% |
| 2023 | 0.55x | CN¥136.91 Million | CN¥75.15 Million | ▲ +28.1% |
| 2022 | 0.43x | CN¥126.67 Million | CN¥54.26 Million | ▲ +336.4% |
| 2021 | 0.10x | CN¥148.60 Million | CN¥14.58 Million | ▼ -50.3% |
| 2020 | 0.20x | CN¥131.10 Million | CN¥25.91 Million | — |